Identifying Neuroimaging Biomarkers of Psychosis Onset

Investigation of peripheral complement factors across stages of psychosis

L Laskaris, A Zalesky, CS Weickert, MA Di Biase, G Chana, BT Baune, C Bousman, B Nelson, P McGorry, I Everall, C Pantelis, V Cropley

2019-02-01

The complement cascade has been proposed to contribute to the pathogenesis of schizophrenia. However, it remains unclear whether p..

Microglial activation and progressive brain changes in schizophrenia

LE Laskaris, MA Di Biase, I Everall, G Chana, A Christopoulos, E Skafidas, VL Cropley, C Pantelis

2016-02-01

Schizophrenia is a debilitating disorder that typically begins in adolescence and is characterized by perceptual abnormalities, de..

Effects of oxytocin and genetic variants on brain and behaviour: Implications for treatment in schizophrenia

CF Bartholomeusz, EP Ganella, I Labuschagne, C Bousman, C Pantelis

2015-11-01

Impairments in social cognition and poor social functioning are core features of schizophrenia-spectrum disorders. In recent years..

The melbourne assessment of schizotypy in kids: A useful measure of childhood schizotypal personality disorder

HP Jones, RR Testa, N Ross, ML Seal, C Pantelis, B Tonge

2015-01-06

Despite being identified as a high risk cohort for psychosis, there has been relatively little research on the clinical presentati..

Relationship between membrane fatty acids and cognitive symptoms and information processing in individuals at ultra-high risk for psychosis

SW Kim, MR Schäfer, CM Klier, M Berk, S Rice, K Allott, CF Bartholomeusz, SL Whittle, E Pilioussis, C Pantelis, PD McGorry, GP Amminger

2014-01-01

Cognitive symptoms and impairment are central to schizophrenia and often an early sign of this condition. The present study invest..